The annual translational science research day, now in its 12th year and scheduled to take place on May 5, was renamed as a well-deserved tribute based on the sentiments shared by colleagues who acknowledged Robert A. Clark, MD, MACP, and his years of outstanding leadership, intelligence, objective listening, guidance and support.

“I was completely surprised when the idea was presented to me as we discussed the agenda for the upcoming research day,” shared Dr. Clark, who stepped down this year after serving as the founding director of The Institute for the Integration of Medicine and Science (IIMS) for 15 years. “I am pleased and grateful for the recognition.”

Mark P. Goldberg, MD, who follows Dr. Clark as the new director of the IIMS, credits Dr. Clark’s pioneering role in the translational science field and the collaborative effort required to secure National Institutes of Health funding on its initial application in 2006. The funding has been renewed twice. “By naming research day after Bob, we not only honor his legacy, but elevate our event nationally given his reputation. A hallmark of the CTSA is early-career development of scientists in advancing discovery to the patient. I am learning firsthand how much time and energy our faculty give to the success of graduate students and trainees. It is truly admirable.” 

Dr. Clark has no intentions of slowing down and will continue at UT Health San Antonio as a full-time professor. He looks forward to devoting more time in his lab focused on the inflammation and aging in neurogenerative diseases. His other goal is to advance The Perry & Ruby Stevens Parkinson’s Disease Center of Excellence to national recognition.